{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:28:11Z","timestamp":1793327291266,"version":"4.5.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Antibody-mediated rejection (AMR) after liver transplantation (LT) is increasingly recognized as a cause of graft dysfunction, chronic injury, and graft loss, but remains difficult to diagnose because serologic, histologic, and clinical findings are often incomplete or overlapping. This review focuses specifically on liver AMR and distinguishes liver-specific evidence from mechanisms inferred from experimental models or other solid-organ transplants. We summarize how donor-specific antibodies (DSA), complement activation, Fc receptor-mediated effector mechanisms, endothelial activation, and microvascular inflammation interact with the liver graft\u2019s relative resistance to humoral injury. We also discuss the diagnostic overlap among acute AMR, chronic AMR, T cell-mediated rejection, and plasma cell-rich rejection, and propose a practical diagnostic-therapeutic framework integrating DSA, C4d, histology, graft dysfunction, and mechanism-based treatment options.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1838990","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:47:46Z","timestamp":1780462066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunopathogenesis of antibody-mediated rejection in liver transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Bo","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplantation Surgery, The First People\u2019s Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplantation Surgery, The First People\u2019s Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplantation Surgery, The First People\u2019s Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplantation Surgery, The First People\u2019s Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyi","family":"Mang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplantation Surgery, The First People\u2019s Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengning","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplantation Surgery, The First People\u2019s Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13232","article-title":"Antibody-mediated rejection in liver transplantation: Immuno-pathological characteristics and long-term follow-up","volume":"37","author":"Cicalese","year":"2024","journal-title":"Transpl Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.101363","article-title":"Rejection in liver transplantation recipients","volume":"14","author":"Maddur","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff Working Group on liver allograft pathology: Introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.027","article-title":"Antibody-mediated rejection of the liver allograft: An update and a clinico-pathological perspective","volume":"75","author":"Lee","year":"2021","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.030","article-title":"Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation","volume":"78","author":"Montano-Loza","year":"2023","journal-title":"J Hepatol"},{"key":"B6","article-title":"The role of donor-specific HLA alloantibodies in liver transplantation","volume":"14","author":"O'Leary","year":"2014","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v14.i1.287","article-title":"Acute liver failure secondary to acute antibody mediated rejection after compatible liver transplant: A case report","volume":"14","author":"Robinson","year":"2022","journal-title":"World J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.70149","article-title":"Clinical features and treatment of antibody-mediated rejection after liver transplantation: A largest single center experience in China","volume":"39","author":"Wu","year":"2025","journal-title":"Clin Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02155","article-title":"The immunological basis of liver allograft rejection","volume":"11","author":"Ronca","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01227","article-title":"The human immune response to cadaveric and living donor liver allografts","volume":"11","author":"Hann","year":"2020","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/mot.0000000000000825","article-title":"Donor-specific antibodies in liver transplantation: Challenges in diagnosis and determining clinical impact","volume":"25","author":"Kim","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/mot.0000000000000194","article-title":"ABO-compatible liver allograft antibody-mediated rejection: An update","volume":"20","author":"Demetris","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.humpath.2022.06.015","article-title":"Acute antibody-mediated rejection in liver transplantation: Impact and applicability of the Banff working group on liver allograft pathology 2016 criteria","volume":"127","author":"Maurice","year":"2022","journal-title":"Hum Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25663","article-title":"Outcome of liver transplant patients with preformed donor-specific anti-human leukocyte antigen antibodies","volume":"26","author":"Del Bello","year":"2020","journal-title":"Liver Transpl"},{"key":"B16","doi-asserted-by":"crossref","first-page":"613128","DOI":"10.3389\/fimmu.2020.613128","article-title":"De Novo donor specific antibody and long-term outcome after liver transplantation: A systematic review and meta-analysis","volume":"11","author":"Beyzaei","year":"2020","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cld.871","article-title":"Donor-specific antibodies in liver transplantation","volume":"15","author":"Nilles","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i2.101620","article-title":"Human leukocyte antigen and donor-specific antibodies in liver transplantation","volume":"31","author":"Qimudesiren","year":"2025","journal-title":"World J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0b013e31817c4cb8","article-title":"Human leukocyte antigen antibodies and chronic rejection: From association to causation","volume":"86","author":"Terasaki","year":"2008","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1111\/tri.13763","article-title":"De novo HLA class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study","volume":"33","author":"Kovandova","year":"2020","journal-title":"Transpl Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003469","article-title":"Clinicopathologic characteristics of late acute antibody-mediated rejection in pediatric liver transplantation","volume":"105","author":"Zhou","year":"2021","journal-title":"Transplantation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2024.1403096","article-title":"The fate of anti-HLA antibodies following liver transplantation","volume":"4","author":"Norman","year":"2024","journal-title":"Front Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v13.i6.673","article-title":"Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation","volume":"13","author":"Schotters","year":"2021","journal-title":"World J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13010041","article-title":"Acute antibody-mediated rejection in liver transplant recipients with autoimmune liver disease: A clinical and pathologic study of 4 cases","volume":"13","author":"Jiang","year":"2022","journal-title":"J Pers Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2025.111289","article-title":"The impact of donor-specific antibody and non-HLA antibodies on acute cellular rejection in pediatric liver transplantation","volume":"86","author":"Xu","year":"2025","journal-title":"Hum Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/lvt.0000000000000084","article-title":"Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation","volume":"29","author":"Tajima","year":"2023","journal-title":"Liver Transpl"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14997","article-title":"Morphologic and immunophenotypic evaluation of liver allograft biopsies with contemporaneous serum DSA measurements","volume":"37","author":"El Hag","year":"2023","journal-title":"Clin Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i33.3837","article-title":"Human leukocyte antigen compatibility and incidence of donor-specific antibodies in pediatric liver transplant recipients","volume":"30","author":"Melere","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.12659\/aot.904867","article-title":"C1q test for identification of sensitized liver recipients at risk of early acute antibody-mediated rejection","volume":"22","author":"Kozlowski","year":"2017","journal-title":"Ann Transplant"},{"key":"B30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12876-020-01427-4","article-title":"HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level","volume":"20","author":"Willuweit","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"20251078","DOI":"10.1002\/jbt.21998","article-title":"Effects of de novo donor-specific class I and II antibodies on graft outcomes after liver transplantation: A pilot cohort study","volume":"20","author":"Altundas","year":"2025","journal-title":"Open Life Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02380","article-title":"The role of complement in organ transplantation","volume":"10","author":"Grafals","year":"2019","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30508","article-title":"The role of complement in liver injury, regeneration, and transplantation","volume":"70","author":"Thorgersen","year":"2019","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2021.08.065","article-title":"Intra-liver allograft C3d-binding donor-specific anti-HLA antibodies predict rejection after liver transplantation","volume":"54","author":"Nakamura","year":"2022","journal-title":"Transplant Proc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003298","article-title":"Natural killer cells: Critical effectors during antibody-mediated rejection of solid organ allografts","volume":"105","author":"Miyairi","year":"2021","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003741","article-title":"Cellular and molecular crosstalk of graft endothelial cells during AMR: Effector functions and mechanisms","volume":"105","author":"Charreau","year":"2021","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10465","article-title":"The role of Fc gamma receptors in antibody-mediated rejection of kidney transplants","volume":"35","author":"Delpire","year":"2022","journal-title":"Transpl Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/mot.0000000000000275","article-title":"Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'","volume":"21","author":"Kim","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/tan.70211","article-title":"Clinical significance of post-transplant HLA class II donor-specific antibodies in the development of rejection and clinical outcomes in paediatric liver transplantation: A retrospective single-centre study","volume":"105","author":"Kang","year":"2025","journal-title":"HLA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701259","article-title":"HLA class II-triggered signaling cascades cause endothelial cell proliferation and migration: Relevance to antibody-mediated transplant rejection","volume":"200","author":"Jin","year":"2018","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-022-02307-9","article-title":"HLA class II antibody activation of endothelial cells induces M2 macrophage differentiation in peripheral blood","volume":"27","author":"Guo","year":"2023","journal-title":"Clin Exp Nephrol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800333","article-title":"Critical role of macrophage FcgammaR signaling and reactive oxygen species in alloantibody-mediated hepatocyte rejection","volume":"201","author":"Zimmerer","year":"2018","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.10.020","article-title":"Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy","volume":"24","author":"Nevarez-Mejia","year":"2024","journal-title":"Am J Transplant"},{"key":"B44","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/lt.25187","article-title":"Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients","volume":"24","author":"Dao","year":"2018","journal-title":"Liver Transpl"},{"key":"B45","article-title":"Chronic AMR in liver transplant: Validation of the 1-year cAMR score's ability to determine long-term outcome","volume":"101","author":"O'Leary","year":"2017","journal-title":"Transplantation"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300363","article-title":"The transplant bellwether: Endothelial cells in antibody-mediated rejection","volume":"211","author":"Franco-Acevedo","year":"2023","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13611","article-title":"Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy","volume":"24","author":"Schluckebier","year":"2020","journal-title":"Pediatr Transplant"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s307778","article-title":"Donor-specific antibodies against donor human leukocyte antigen are associated with graft inflammation but not with fibrosis long-term after liver transplantation: An analysis of protocol biopsies","volume":"14","author":"Gul-Klein","year":"2021","journal-title":"J Inflammation Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164834","article-title":"The new challenge in pediatric liver transplantation: Chronic antibody-mediated rejection","volume":"11","author":"Uebayashi","year":"2022","journal-title":"J Clin Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.08.002","article-title":"Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation","volume":"23","author":"Terry","year":"2023","journal-title":"Am J Transplant"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4674397","article-title":"Single-cell and bulk RNA sequencing highlights the role of M1-like infiltrating macrophages in antibody-mediated rejection after kidney transplantation","volume":"10","author":"Pang","year":"2024","journal-title":"Heliyon"},{"key":"B52","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41423-023-01058-1","article-title":"Neutrophil diversity and plasticity: Implications for organ transplantation","volume":"20","author":"Qu","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823511","article-title":"Neutrophil extracellular traps regulate HMGB1 translocation and Kupffer cell M1 polarization during acute liver transplantation rejection","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2020.101286","article-title":"A potential role of neutrophil extracellular traps (NETs) in kidney acute antibody mediated rejection","volume":"60","author":"Torres-Ruiz","year":"2020","journal-title":"Transpl Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.04.018","article-title":"The role of neutrophil extracellular trap formation in kidney transplantation: Implications from donors to the recipient","volume":"24","author":"van Zyl","year":"2024","journal-title":"Am J Transplant"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.444","article-title":"Role of the immune system in liver transplantation and its implications for therapeutic interventions","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm (2020)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.921212","article-title":"Human hepatic CD56(bright) NK cells display a tissue-resident transcriptional profile and enhanced ability to kill allogenic CD8(+) T cells","volume":"13","author":"Jameson","year":"2022","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"23499","DOI":"10.1038\/s41598-025-06456-1","article-title":"Donor liver natural killer cells ameliorate liver allograft rejection via inducing apoptosis of alloreactive CD8(+) T cells generating CD4(+)CD25(+) regulatory T cells","volume":"15","author":"Yu","year":"2025","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13209","article-title":"Natural killer cell presence in antibody-mediated rejection","volume":"37","author":"Diebold","year":"2024","journal-title":"Transpl Int"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13208","article-title":"Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance","volume":"15","author":"Halma","year":"2022","journal-title":"Clin Transl Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2025.100986","article-title":"The role of natural killer cells in the immune response after liver transplantation","volume":"40","author":"Gao","year":"2026","journal-title":"Transplant Rev (Orlando)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajt.2022.10.006","article-title":"CD16(+) natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction","volume":"23","author":"Calabrese","year":"2023","journal-title":"Am J Transplant"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00288","article-title":"Antibody-dependent NK cell activation is associated with late kidney allograft dysfunction and the complement-independent alloreactive potential of donor-specific antibodies","volume":"7","author":"Legris","year":"2016","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.1517\/14728222.2016.1135904","article-title":"Molecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and future","volume":"20","author":"Galian","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/txd.0000000000000932","article-title":"Bortezomib against refractory antibody-mediated rejection after ABO-incompatible living-donor liver transplantation: Dramatic effect in acute-phase","volume":"5","author":"Tajima","year":"2019","journal-title":"Transplant Direct"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2022.2128374","article-title":"Memory B cells and long-lived plasma cells in AMR","volume":"44","author":"Yue","year":"2022","journal-title":"Ren Fail"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14336","article-title":"Presence of donor specific HLA class 2 antibodies (DSA class 2) is associated with\u00a0development of graft fibrosis more than 10 years after liver transplantation-a retrospective single center study","volume":"35","author":"Sultani","year":"2021","journal-title":"Clin Transplant"},{"key":"B69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ajcp\/aqad004","article-title":"Histologic and clinical outcomes of patients developing post-liver transplant plasma cell-rich rejection","volume":"160","author":"Ozturk","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.10.006","article-title":"Serum and tissue biomarkers of plasma cell-rich rejection in liver transplant recipients","volume":"25","author":"Saravanan","year":"2025","journal-title":"Am J Transplant"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29953","article-title":"Roles of BATF\/JUN\/IRF4 complex in tacrolimus mediated immunosuppression on Tfh cells in acute rejection after liver transplantation","volume":"236","author":"Tang","year":"2021","journal-title":"J Cell Physiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111103","article-title":"Polymorphisms in genes involved in regulating follicular helper T cell differentiation predict de novo donor-specific antibody formation after liver transplantation","volume":"85","author":"Ono","year":"2024","journal-title":"Hum Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/ajt.15517","article-title":"Circulating T follicular helper cells are a biomarker of humoral alloreactivity and predict donor-specific antibody formation after transplantation","volume":"20","author":"La Muraglia","year":"2020","journal-title":"Am J Transplant"},{"key":"B74","doi-asserted-by":"crossref","first-page":"1275933","DOI":"10.3389\/fimmu.2024.1275933","article-title":"T follicular helper cells expansion in transplant recipients correlates with graft infiltration and adverse outcomes","volume":"15","author":"Desy","year":"2024","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2018.01.003","article-title":"A pilot study on the characteristics of circulating T follicular helper cells in liver transplant recipients","volume":"47","author":"Zhang","year":"2018","journal-title":"Transpl Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40472-021-00331-4","article-title":"IL-6 directed therapy in transplantation","volume":"8","author":"Miller","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"21687","DOI":"10.1038\/s41598-024-71102-1","article-title":"Interleukin 6 and interleukin 17A serum levels and gene- polymorphisms in the development of early allograft rejection in living donor liver transplant recipients","volume":"14","author":"Awad","year":"2024","journal-title":"Sci Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.21037\/atm-22-4311","article-title":"Characteristics of pre-sensitization-related acute antibody-mediated rejection in a rat model of orthotopic liver transplantation","volume":"10","author":"Mang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23266","article-title":"Dual roles of IL-22 at ischemia-reperfusion injury and acute rejection stages of rat allograft liver transplantation","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.11994","article-title":"The effect of anti-HLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation","volume":"23","author":"Eleftheriadis","year":"2021","journal-title":"Mol Med Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000002194","article-title":"IL-34 inhibits acute rejection of rat liver transplantation by inducing Kupffer cell M2 polarization","volume":"102","author":"Zhao","year":"2018","journal-title":"Transplantation"},{"key":"B82","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10020-025-01153-1","article-title":"LXRalpha agonists ameliorates\u00a0acute rejection after liver transplantation via ABCA1\/MAPK and PI3K\/AKT\/mTOR signaling axis in macrophages","volume":"31","author":"Qin","year":"2025","journal-title":"Mol Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41598-024-81832-x","article-title":"ANGPTL4 induces Kupffer cell M2 polarization to mitigate acute rejection in liver transplantation","volume":"15","author":"Huang","year":"2025","journal-title":"Sci Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1649366","article-title":"Inhibition of HMGB1\/NF-kappaB signaling restores Th17\/Treg balance via dendritic cell modulation in liver transplant rejection","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"crossref","first-page":"9276831","DOI":"10.1155\/2019\/9276831","article-title":"Gastrodin ameliorates acute rejection via IRE1alpha\/TRAF2\/NF-kappaB in rats receiving liver allografts","volume":"2019","author":"Yuan","year":"2019","journal-title":"BioMed Res Int"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: Role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186653","article-title":"Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats","volume":"14","author":"Tajima","year":"2023","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16484","article-title":"Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation","volume":"21","author":"Mohammed","year":"2021","journal-title":"Am J Transplant"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.661580","article-title":"IL-21 receptor blockade shifts the follicular T cell balance and reduces de novo donor-specific antibody generation","volume":"12","author":"Nian","year":"2021","journal-title":"Front Immunol"},{"key":"B90","article-title":"Proposed diagnostic criteria for chronic antibody-mediated rejection in liver allografts","volume":"16","author":"O'Leary","year":"2016","journal-title":"Am J Transplant"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1963","article-title":"Antibody-mediated rejection in adult liver transplant recipients: A case series and literature review","volume":"62","author":"Baradaran","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1097\/lvt.0000000000000239","article-title":"Antibody-mediated rejection in liver transplant recipients: Some questions, some answers","volume":"29","author":"De Martin","year":"2023","journal-title":"Liver Transpl"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.101345","article-title":"Basics and art of immunosuppression in liver transplantation","volume":"14","author":"Poudel","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2023.03.093","article-title":"Dual antibody treatment for simultaneous acute cellular rejection and antibody-mediated rejection after liver transplantation: A case report","volume":"55","author":"Furukawa","year":"2023","journal-title":"Transplant Proc"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1097\/lvt.0000000000000200","article-title":"Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study","volume":"29","author":"Dumortier","year":"2023","journal-title":"Liver Transpl"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003551","article-title":"A comprehensive overview of the clinical relevance and treatment options for antibody-mediated rejection associated with non-HLA antibodies","volume":"105","author":"Kardol-Hoefnagel","year":"2021","journal-title":"Transplantation"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/txd.0000000000001180","article-title":"Rituximab desensitization in liver transplant recipients with preformed donor-specific HLA antibodies: A Japanese nationwide survey","volume":"7","author":"Akamatsu","year":"2021","journal-title":"Transplant Direct"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13643","article-title":"The efficacy of rituximab treatment for antibody-mediated rejection in liver transplantation: A retrospective Japanese nationwide study","volume":"51","author":"Sakamoto","year":"2021","journal-title":"Hepatol Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.12659\/aot.941456","article-title":"Clinical outcomes of administration of rituximab for desensitization in liver transplant patients with preformed donor-specific antibodies: A single-center experience","volume":"28","author":"Shizuku","year":"2023","journal-title":"Ann Transplant"},{"key":"B100","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/ajt.17207","article-title":"Importance of IL-6 inhibition in prevention and treatment of antibody-mediated rejection in kidney allografts","volume":"22","author":"Jordan","year":"2022","journal-title":"Am J Transplant"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.682334","article-title":"Approaches for controlling antibody-mediated allograft rejection through targeting B cells","volume":"12","author":"Matsuda","year":"2021","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation","volume":"12","author":"Paterno","year":"2012","journal-title":"Am J Transplant"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2021.11.022","article-title":"Refractory acute antibody mediated rejection in liver transplant after desensitization of preformed donor specific antibody-validity of bortezomib and everolimus: a case report","volume":"54","author":"Komagome","year":"2022","journal-title":"Transplant Proc"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1590\/0100-6991e-20243689-en","article-title":"Indications and outcomes of liver retransplantation in three medical centers","volume":"51","author":"Schiel","year":"2024","journal-title":"Rev Col Bras Cir"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14318","article-title":"Autoantibodies to LG3 are associated with poor long-term survival after liver retransplantation","volume":"35","author":"Xu","year":"2021","journal-title":"Clin Transplant"},{"key":"B106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10620-024-08741-x","article-title":"Indications and outcomes with liver retransplantation in 2025","volume":"70","author":"Likhitsup","year":"2025","journal-title":"Dig Dis Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf108","article-title":"Targeting IL-6 in antibody-mediated kidney transplant rejection","volume":"18","author":"Kanbay","year":"2025","journal-title":"Clin Kidney J"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000004784","article-title":"Feasibility of interleukin-6 receptor blockade in cardiac antibody-mediated rejection","volume":"108","author":"Pottebaum","year":"2024","journal-title":"Transplantation"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1838990\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:47:52Z","timestamp":1780462072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1838990\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":108,"alternative-id":["10.3389\/fimmu.2026.1838990"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1838990","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1838990"}}